CoChat

The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review

Woods, Anne Dabrow, Giometti, Renee, Weeks, Susan M · 2015 · JBI Database of Systematic Reviews and Implementation Reports

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Chronic alcohol consumption is a prevalent issue. Healthcare professionals often discover their patient has an alcohol consumption issue when they are admitted to the hospital and no longer have access to alcohol. The global standard for treating alcohol withdrawal syndrome (AWS) symptoms are benzodiazepines; however this therapy is often inadequate to control symptoms of delirium in adult intensive care unit (ICU) patients due to an imbalance of inhibitory and excitatory neurotransmitters. OBJECTIVES: The objective of the systematic review is to examine the clinical effectiveness of dexmedetomidine as an adjuvant to benzodiazepine-based therapy versus benzodiazepine-based therapy alone in decreasing the severity of delirium associated with AWS in adult ICU patients. INCLUSION CRITERIA: This review considered studies that included adult ICU patients over the age of 18 who were experiencing delirium associated with alcohol withdrawal. Patients admitted to the ICU with the diagnosis of AWS were included in the study.This review considered studies that evaluated dexmedetomidine as an adjuvant therapy to benzodiazepine-based therapy, compared to the use of benzodiazepine-based therapy alone in ICU patients experiencing alcohol withdrawal delirium.This review considered randomized controlled trials, non-randomized controlled trials, quasi-experimental, before and after studies, prospective and retrospective cohort studies, case control studies, analytical cross sectional studies, case series, individual case reports and descriptive cross sectional studies for inclusion.The systematic review evaluated dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease delirium severity in alcohol withdrawal in ICU patients. The general outcome of delirium severity was measured using the Clinical Institute Withdrawal Assessment Score - Revised (CIWA), the Ramsey scale, the Richmond Agitation Sedation Score (RASS) and the Confusion Assessment Method for the ICU (CAM-ICU). SEARCH STRATEGY: The search strategy aimed to find both published and unpublished studies. A three-step search strategy was utilized in this review and included English language studies published after 1997. A search of Ovid/MEDLINE, EMBASE, Cochrane, Joanna Briggs Institute and nine other databases was conducted. METHODOLOGICAL QUALITY: Two independent reviewers using the Joanna Briggs Institute's standardized appraisal tool critically appraised the studies. A third independent reviewer was available to appraise studies if the two original reviewers disagreed in their assessments. There were no disagreements in findings between the two independent reviewers. DATA COLLECTION: Data was extracted using the standardized Joanna Briggs Institute's data extraction instruments. DATA SYNTHESIS: Statistical pooling was done using meta-analysis and findings are presented using a forest plot and narrative form. RESULTS: Four studies were included in the review, three retrospective case series and one prospective case series with a total sample size of 55 patients. Three studies used the CIWA score as the outcome measure and one study used the RASS score as the outcome measure. A meta-analysis of the three studies using the CIWA demonstrated that adjuvant use of dexmedetomidine with benzodiazepine-based therapy decreased CIWA scores (Weighted Mean Difference [WMD] -5.2, 95% Confidence Interval [CI] -6.24 to -4.16, p <0.0001). The final study using RASS scores reported improvement with adjuvant treatment with dexmedetomidine compared to benzodiazepine-based therapy alone. CONCLUSIONS: The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy decreased delirium more effectively than benzodiazepine-based therapy alone in adult ICU patients experiencing alcohol withdrawal delirium as evidenced by a decrease in CIWA and RASS scores. IMPLICATIONS FOR PRACTICE: In adult ICU patients who are experiencing alcohol withdrawal delirium that is not controlled with benzodiazepine-based therapy alone, healthcare providers should consider dexmedetomidine as an adjuvant to standard benzodiazepine-based therapy. IMPLICATIONS FOR RESEARCH: The use of dexmedetomidine in the management of delirium associated with alcohol withdrawal in adult ICU patients should be further studied via large scale randomized controlled trials.

Overview

Integrity signals

Registry

Crossref · 10.11124/jbisrir-2015-1602

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 36 references

Research works printed but not linked: 4

  1. Bayard, 2004, Am Fam Physician, 69, 1443
  2. Holbrook, 1999, Can Med Assoc J, 160, 649
  3. Reoux, 2001, Alcohol Clin Exp Res, 25, 1324, 10.1111/j.1530-0277.2001.tb02354.x · doi:10.1111/j.1530-0277.2001.tb02354.x · Paper page
  4. Myrick, 1998, Alcohol Health Res World, 22, 38

Cited by

See all 28

Metadata

Authors
Woods, A. D., Giometti, R., & Weeks, S. M.
Affiliations
  • Texas Christian University (US)
  • Chester County Hospital (US)
Venue
JBI Database of Systematic Reviews and Implementation Reports
Published
2015-01
Volume
13
Issue
1
Pages
224-252
ISSN
2202-4433 (ISSN-L)
OpenAlex
W2133052062
Cited by
23
References
36
Citations by year
2026: 1 · 2024: 2 · 2023: 1 · 2022: 5 · 2021: 2 · 2020: 3 · 2019: 5 · 2018: 2 · 2017: 1 · 2015: 1
FWCI
0.18
Type
journal article
Language
en
Open access
closed
Locations
  • The JBI Database of Systematic Reviews and Implementation Reports (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Pennsylvania
  • Texas Christian University
Topics
  • Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Sedative Agents
Keywords
dexmedetomidine, alcohol withdrawal, delirium, benzodiazepines, adjuvant therapy, intensive care unit patients, delirium severity, Richmond Agitation-Sedation Scale, CAM-ICU, delirium tremens, sedation, agitation, cost-effectiveness
MeSH terms
Adjuvants, Pharmaceutic, Alcohol Withdrawal Delirium, Alcoholism, Benzodiazepines, Cross-Sectional Studies, Delirium, Female, Humans, Intensive Care Units, Male, Middle Aged, Prospective Studies, Retrospective Studies, Severity of Illness Index, Meta-Analysis as Topic, Case-Control Studies, Randomized Controlled Trials as Topic, Treatment Outcome, Dexmedetomidine, Adrenergic alpha-2 Receptor Agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review. https://app.cochat.ai/papers/10.11124/jbisrir-2015-1602
The paper
Woods, A. D., Giometti, R., & Weeks, S. M. (2015). The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review. JBI Database of Systematic Reviews and Implementation Reports. https://doi.org/10.11124/jbisrir-2015-1602

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.